AI steps in to solve a rare disease diagnosis puzzle
NCT ID NCT07275190
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study collects medical data from 60 adults diagnosed with either EGPA or HES, two rare conditions that cause high levels of a type of white blood cell. Researchers will use artificial intelligence to find patterns that help doctors tell the diseases apart and predict how patients will respond to treatment. The goal is to improve diagnosis and personalize care for these hard-to-distinguish illnesses.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EGPA - EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fondazione IRCCS Policlinico San Matteo, SC Reumatologia
RECRUITINGPavia, 27100, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.